GAMCO Investors’s Intersect ENT, Inc XENT Stock Holding History

GAMCO Investors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-84,434	Closed	-$2.37M	–	938
2022 Q1	$2.37M	Buy	84,434 +5,884	+7%	+$161K	0.02%	477
2021 Q4	$2.15M	Sell	78,550 -781	-1%	-$21.2K	0.02%	493
2021 Q3	$2.16M	Buy	79,331 +26,281	+50%	+$650K	0.02%	493
2021 Q2	$907K	Sell	53,050 -1,500	-3%	-$28.1K	0.01%	660
2021 Q1	$1.14M	Sell	54,550 -8,000	-13%	-$185K	0.01%	605
2020 Q4	$1.43M	Buy	62,550 +3,000	+5%	+$57.1K	0.01%	542
2020 Q3	$971K	Buy	59,550 +30,550	+105%	+$553K	0.01%	572
2020 Q2	$393K	Buy	+29,000	New	+$337K	﹤0.01%	698

GAMCO Investors's XENT Position: Q2 2022 in Review

GAMCO Investors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 84,434 shares — an estimated $2.37M sold.

GAMCO Investors first reported a position in XENT in Q2 2020 and held it in 8 quarters. The position peaked at $2.37M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

GAMCO Investors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
GAMCO Investors sold 84,434 Intersect ENT, Inc shares in Q2 2022, an estimated $2.37M.
GAMCO Investors first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 8 quarters.
GAMCO Investors's Intersect ENT, Inc position peaked at $2.37M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on GAMCO Investors's 13F filing for Q2 2022, filed 12 Aug 2022.